Therefore, antibodies induced by the BLSOmp3/IFA formulation may promote the killing the B.canis by complement activation, by enchancing opsonization and phagocytosis or by promoting antibody-dependent cellular toxicity by NK (or other killer cells) during the extracellular life of this pathogen in sera or in mucosal tissues